Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
39.2M
-
Shares change
-
+2.28M
-
Total reported value, excl. options
-
$216M
-
Value change
-
+$6.84M
-
Put/Call ratio
-
0.12
-
Number of buys
-
45
-
Number of sells
-
-58
-
Price
-
$5.51
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2022
132 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.2M shares
of 170M outstanding shares and own 23.09% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (7.22M shares), EVENTIDE ASSET MANAGEMENT, LLC (5.37M shares), Alpine Global Management, LLC (3.86M shares), VANGUARD GROUP INC (3.77M shares), BlackRock Inc. (3.35M shares), FEDERATED HERMES, INC. (1.9M shares), Octagon Capital Advisors LP (1.48M shares), STATE STREET CORP (836K shares), TWO SIGMA INVESTMENTS, LP (822K shares), and GEODE CAPITAL MANAGEMENT, LLC (789K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.